Back to top Open menu arrow
Download Reprints
Sections
Summary Clinical Points
Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders
Access icon

Narrative Review September 23, 2021

Perinatal Planning Guide: Mitigating Perinatal Mood and Anxiety Disorders During the COVID-19 Pandemic

Leah C. Susser, MD; Victoria M. Wilkins, PhD; Lauren H. Sternberg, PsyD

Prim Care Companion CNS Disord 2021;23(5):21nr02953

ABSTRACT

Women are at high risk for and more vulnerable to perinatal mood and anxiety disorders (PMADs) during the coronavirus disease 2019 (COVID-19) pandemic. While access to specialized perinatal mental health services is limited, clinicians with whom women have ongoing relationships are in a unique position to counsel about prevention of PMADs. These clinicians include primary care, obstetric, and general mental health clinicians. By providing a woman with practical guidance and psychoeducation for perinatal planning (eg, about sleep, exercise, nutrition, and the importance of social supports), clinicians can mitigate a woman’s risk of PMADs. This practical guidance must be modified to fit the social context of the COVID-19 pandemic. This guidance can prevent or attenuate unnecessary suffering on the part of the mother and have a long-lasting impact on her child. This review provides a perinatal planning guide that outlines important topics to discuss and problem solve with women in the context of the COVID-19 pandemic.

Prim Care Companion CNS Disord 2021;23(5):21nr02953

To cite: Susser LC, Wilkins VM, Sternberg LH. Perinatal planning guide: mitigating perinatal mood and anxiety disorders during the COVID-19 pandemic. Prim Care Companion CNS Disord. 2021;23(5):21nr02953.
To share: https://doi.org/10.4088/PCC.21nr02953

© Copyright 2021 Physicians Postgraduate Press, Inc.

aWeill Cornell Medicine, White Plains, New York
bNewYork-Presbyterian Hospital, White Plains, New York
*Corresponding author: Leah C. Susser, MD, 21 Bloomingdale Rd, Outpatient Department, White Plains, NY 10605 ([email protected]).

 

 

The perinatal period is well recognized as a psychologically vulnerable period for new and expecting mothers. While prevalence varies greatly between countries, the prevalence of postpartum depression is around 17.7%1 while 18%–22% of perinatal women are affected by anxiety.2–4 Furthermore, the consequences of untreated perinatal mood and anxiety disorders (PMADs) are large. PMADs are associated with significant morbidity and mortality in women5–7 and can negatively impact offspring development into adulthood.8,9 During the coronavirus disease 2019 (COVID-19) pandemic, PMADs have become even more common. Nevertheless, access to specialized perinatal mental health care is scarce. Consequently, clinicians with whom women have on-going relationships are in a unique position to identify those at risk of PMADs and to decrease their risk of relapse. Quick interventions, including psychoeducation about maximizing sleep, increasing self-care, preventing isolation, and mobilizing supports, can have a profound impact. Here, we present a perinatal planning guide with practical tips for mitigating risk of PMADs. These general principles are applicable to the perinatal period both during and outside of the COVID-19 pandemic, and we additionally discuss modifications for the pandemic.

PMAD Risk Factors

Identification of modifiable risk factors for PMADs provides an opportunity to intervene and prevent perinatal relapse and worsening of psychiatric symptoms. Major risk factors for postpartum depression include antenatal depression, antenatal anxiety, low social support, psychiatric history, life stress, childcare stress, and postpartum blues.4,10–12 Similarly, early postpartum anxiety or depression, life stress, childcare stress, psychiatric history, and low general social and/or family support place a woman at risk for postpartum anxiety.3 Lastly, decreased sleep can impact mood stability and anxiety.13–16

Impact of the COVID-19 Pandemic on Maternal Mental Health

High levels of perinatal depression, anxiety, and stress during the pandemic have been demonstrated in studies from countries across the world, despite different lockdown restrictions, COVID-19 rates, health care systems, and perinatal support systems.17–25 Moreover, rates of perinatal depression or stress during the pandemic have increased compared to before the pandemic.17–19 Attention to the mental health of perinatal women is vital to preventing relapse and worsening of PMADs.

PMAD Risk Factors and Ameliorating Factors During the COVID-19 Pandemic

During the COVID-19 pandemic, there are multiple factors that may be impacting the increased risk of perinatal mood and anxiety symptoms. Pregnant women may be at higher risk of more severe COVID-19 illness.26,27 They also experience stress related to the unknowns during the COVID-19 pandemic, including exposure and obstetric care during pregnancy and delivery.28 In addition to the woman’s fear of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its effect on her fetus or infant, the social support network available in the perinatal period during the pandemic has changed drastically. She may now have limited access to traditional social support systems and be more physically isolated. Pregnancy, which had been a public experience, during the COVID-19 pandemic has become more private.28 In the postpartum, she may not have access to the same in-person supports, including in-person help from friends, family, caregivers, and clinicians. She may now be working full-time from home while caring for her infant or children or have anxiety about or actual loss of job or housing. Certain women may be at higher risk of PMADs with these changes, such as women with a prior psychiatric history.20 However, understanding a woman’s risks for relapse enables intervention to mitigate her risk.

Studies have identified vulnerabilities for PMADs during the COVID-19 pandemic. Women who are more socially isolated and who have lower perceived social support, as well as those with lower socioeconomic status, financial difficulties, or a greater number of recent stressful events are at higher risk for PMADs.20,21,28 Postpartum women also express stress related to childcare help.28 Importantly, there are also striking racial disparities in communities affected by COVID-19, with Black and Hispanic populations being at higher risk for COVID-19 complications.29,30 Perinatal women in these communities that are disproportionately affected by COVID-19 are at higher risk of experiencing loss of close friends or relatives. The general guidelines presented here are readily adaptable to particular communities.

Studies have also investigated mitigating factors for PMADs during the pandemic. Perceived general social support, connecting with other new mothers, and partner support can help lower anxiety and depression symptomatology.21,28 Exercise during the pandemic is also associated with lower anxiety and depression in perinatal women.3,21,25 Navigating social systems, modifying social relationships, and incorporating exercise into routines may be more challenging during the pandemic. Consequently, practical guidance in problem-solving by clinicians is important and may help attenuate PMADs.

Risk:Risk Discussion

While social support is crucial to maternal well-being, the pandemic poses difficult family decisions regarding help during the postpartum period. Families who originally arranged to have grandparents, a nanny, or a night nurse help may no longer feel comfortable due to risk of COVID-19 exposure. A family must consider the risks to a woman’s mental health of not having these supports in the postpartum compared to the risks of COVID-19 exposure and ways to mitigate each risk, including with vaccination. Having these discussions with a woman and her family during pregnancy ensures there is a plan in place to help her in the postpartum. If she is at high risk of postpartum psychiatric illness and vulnerable to sleep deprivation, what support would be practical and acceptable for the family? If the family is considering a night nurse or family support in the postpartum, do they plan to require quarantine or COVID-19 vaccination? If a woman does not have childcare or if her psychiatric illness relapses, will she risk losing her job and potentially their housing? The risk:risk analysis for each family will be different, based on the family’s needs, resources, risks, and the woman’s vulnerability to postpartum psychiatric illness.

For a woman with anxiety or depression, decision-making can be particularly difficult.31,32 Therefore, it is important to help a woman evaluate the risks and benefits of each choice to help her make a plan for postpartum support prior to delivery. A woman might be fearful to leave her home due to risk of infection. However, outdoor exercise can play an important role in relapse prevention and treatment of anxiety and depression,21,25 as well as in overall physical health and potentially in susceptibility to illness by mitigating risk factors for severe COVID-19.33–35 Additionally, it is important to help a woman weigh the risks and benefits of attending in-person prenatal and postpartum obstetric and mental health appointments compared to virtual alternatives. Helping a woman evaluate the risks and benefits of each decision for herself is an important process.

Treatments for PMADs

There are a number of empirically supported interventions for PMADs, including cognitive-behavioral therapy36–38 and interpersonal psychotherapy.39,40 Medications are often an important component of treatment for PMADs, including severe symptomatology in pregnancy.41,42 However, medication management should be in conjunction with maximizing nonpharmacologic techniques, such as maximizing sleep, exercise, behavioral activation, and nutrition. In addition, women with milder symptoms may benefit from lifestyle modifications or psychotherapy alone.15,36,38–40,42–44 Lastly, psychoeducation may be adequate to prevent PMADs in lower risk women.45–47

Perinatal planning plays a critical role in prevention of PMADs. Providing psychoeducation in pregnancy enables a woman to problem solve and gather supports prior to delivery and is imperative to prevent a woman from relapsing after delivery. Additionally, psychoeducational interventions within the first month of the postpartum period can diminish risk of depression, anxiety, or adjustment disorders.47

Lifestyle Modifications During the COVID-19 Pandemic

While psychotherapy is an important component of treatment for PMADs, and while telehealth has the potential to increase access to mental health services,48 many women during the COVID-19 pandemic are not receiving psychotherapy, with many citing lack of time and energy as barriers.20 While addressing obstacles to accessing psychotherapy is important, leveraging the contact mothers have with their current clinicians, including general mental health clinicians, family practitioners, obstetrician-gynecologists, and pediatricians, during the pandemic is another effective way of attenuating PMADs. Clinicians are well-positioned to provide psychoeducation about lifestyle modifications and to help a woman create an individualized perinatal plan to identify ways to engage in lifestyle activities that prevent or lessen the impact of mood or anxiety symptoms. Planning should include identifying ways to mobilize social supports and to overcome obstacles to self-care, such as maximizing sleep, nutrition, and exercise. Involving other caregivers and family members in these discussions can help mobilize the mother’s supports. The pandemic has introduced barriers as well as opportunities to implementing these lifestyle modifications.

The ideal time to begin discussing postpartum support, prevention of PMADs, and self-care is before delivery. Nevertheless, clinicians in the hospital after delivery can play an integral part in providing psychoeducation, particularly when women have not had access to these discussions previously. Women often have limited support persons in the hospital while in labor and delivery during the pandemic, making assessment and support by clinicians in the hospital even more essential. Postpartum nurses provide crucial education to women about postpartum physical care and adding information about mental health to these discussions is essential. Clinicians should ask women about their postpartum support network and plan for help prior to discharge. Additionally, postpartum screening can help identify women who warrant further mental health evaluation and support. The American College of Obstetricians and Gynecologists49 recommends screening all perinatal women for depression and anxiety, including at their postpartum visit. Before the postpartum visit, many women would benefit from screening using a validated instrument and clinical assessment after delivery in the hospital, particularly women at higher risk for PMADs and those endorsing symptoms. It is then important to connect women to resources before they are discharged or to follow them more closely in the postpartum period, recognizing that women may have limited postpartum support due to the pandemic.

Sleep

Sleep can be challenging in the perinatal period,14,50–54 but it is vital to ensuring emotional and physical well-being, including pregnancy outcomes.16,54,55 During pregnancy, consequences of hormonal changes and physical discomfort can contribute to disrupted sleep.56 In the postpartum, infant care needs often lead to significant sleep deficits in mothers and other caregivers, leaving them vulnerable to anxiety and depression.14,16,54 When symptoms are mild, quick interventions can help prevent symptoms from progressing to significant mood episodes and from impairing functioning.57–60 Sleep is anti-inflammatory,61 and inflammatory dysregulation has been implicated in the etiology of depression.62,63 In addition, disrupted sleep has been associated with negative health outcomes, including insulin resistance.64,65 Consequently, it is imperative to provide psychoeducation about the importance of sleep and to help a woman and her family create a plan to maximize her sleep.

The COVID-19 pandemic presents new obstacles to mobilizing supports to help with nighttime infant care and to help a woman maximize her sleep in the postpartum. It is important to help a woman assess the risk of introducing a new caregiver into the home during the COVID-19 pandemic or of exposing elderly grandparents to the family during the pandemic and to brainstorm ways to mitigate these potential COVID-19 exposures. Additionally, after maternal COVID-19 vaccination, the risks and benefits of breastfeeding or pumping compared to giving formula overnight may be different, as the breastmilk contains SARS-CoV-2–specific antibodies.66

Lastly, understanding the nature of a postpartum woman’s sleep disturbance, including distinguishing decreased sleep due to caring for the infant from inability to sleep even when the infant is sleeping, is crucial, as the intervention will differ, and the latter may signify more concerning psychiatric symptomatology.

Nutrition

While there are obstacles to eating well in the perinatal period, nutrition is important for the physical and emotional health of the mother.67–72 Furthermore, nutrients such as folic acid are crucial for fetal development.68,73–76 As a result, it is important to help a woman ensure access to healthy foods and identify supports who can be involved in this effort. However, soliciting help with meal preparation may now be challenging due to risk of transmission of SARS-CoV-2. Additionally, a woman may not feel comfortable taking her infant to the grocery store during the pandemic. It is important to help a woman find alternatives as well as assess the risks and benefits of these exposures.

Exercise

There is evidence that exercise can treat depressive and anxious symptoms, as well as prevent onset of psychiatric symptoms.77–84 Additionally, exercise has been associated with improved sleep quality.85 However, adherence to an exercise regimen in the perinatal period may be difficult.86 During the COVID-19 pandemic, with more limited postpartum support, regular exercise may be even more challenging. Involving family in discussions can help protect time. In addition, virtual classes may be easier to incorporate, and access to virtual opportunities is increasing.

Social Support

The relationship between social support and maternal depression is well-established in clinical research87 and, as discussed previously, has been replicated in studies during the COVID-19 pandemic.88 As a result, helping a woman find ways to decrease social isolation can help prevent PMADs.87 While social contact remains vital to perinatal mental health, opportunities for these connections have changed during the pandemic. Practical hands-on help and social opportunities to connect with others are important considerations. Practical hands-on support in the form of direct infant care and execution of household tasks enables a woman to focus on self-care. Exploring wider sources of support with a woman, including help with childcare needs, is important. While in-person social contacts may have decreased, with improved technology, there are new opportunities to connect with other pregnant and new mothers virtually. Perinatal women may not be aware of many of these new opportunities. Virtual contact can increase access for women in rural areas or those with childcare constraints that previously prevented them from connecting with other perinatal women. Virtual platforms also allow a woman to connect with family and friends afar to feel less isolated. Outdoor, distanced, and masked walks can allow new and expecting mothers to connect during the pandemic. Building support networks and introducing partner sessions in treatment are critical for mitigating risk of PMADs.89

Summary

The practical guidance presented here is generalizable to perinatal women beyond the pandemic. Social supports, sleep, exercise, and nutrition are vital to physical and mental well-being in the perinatal period. By addressing modifiable risk factors for PMADs with concrete tips and creating a perinatal plan tailored to the social circumstances of the era, clinicians can have a profound impact on a woman’s perinatal course and, consequently, on her infant’s development (Table 1).9

Submitted: February 25, 2021; accepted May 4, 2021.
Published online: September 23, 2021.
Potential conflicts of interest: None.
Funding/support: None.

 

Clinical Points

  • Perinatal mood and anxiety disorders (PMADs) are common, especially during the COVID-19 pandemic.
  • Access to specialized perinatal mental health care is scarce; however, psychoeducation by clinicians who have regular contact with perinatal women can help prevent and mitigate PMADs.
  • Nonpharmacologic strategies to mitigate PMADs should be adjusted to the social context of the COVID-19 pandemic.
  1. Hahn-Holbrook J, Cornwell-Hinrichs T, Anaya I. Economic and health predictors of national postpartum depression prevalence: a systematic review, meta-analysis, and meta-regression of 291 studies from 56 countries. Front Psychiatry. 2018;8:248. PubMed CrossRef
  2. Fawcett EJ, Fairbrother N, Cox ML, et al. The prevalence of anxiety disorders during pregnancy and the postpartum period: a multivariate Bayesian meta-analysis. J Clin Psychiatry. 2019;80(4):18r12527. PubMed CrossRef
  3. Dennis CL, Falah-Hassani K, Brown HK, et al. Identifying women at risk for postpartum anxiety: a prospective population-based study. Acta Psychiatr Scand. 2016;134(6):485–493. PubMed CrossRef
  4. Farr SL, Dietz PM, O’Hara MW, et al. Postpartum anxiety and comorbid depression in a population-based sample of women. J Womens Health (Larchmt). 2014;23(2):120–128. PubMed CrossRef
  5. Grigoriadis S, Wilton AS, Kurdyak PA, et al. Perinatal suicide in Ontario, Canada: a 15-year population-based study. CMAJ. 2017;189(34):E1085–E1092. PubMed CrossRef
  6. Shigemi D, Ishimaru M, Matsui H, et al. Suicide attempts among pregnant and postpartum women in Japan: a nationwide retrospective cohort study. J Clin Psychiatry. 2020;81(3):19m12993. PubMed CrossRef
  7. Johannsen BM, Larsen JT, Laursen TM, et al. All-cause mortality in women with severe postpartum psychiatric disorders. Am J Psychiatry. 2016;173(6):635–642. PubMed CrossRef
  8. Plant DT, Pawlby S, Sharp D, et al. Prenatal maternal depression is associated with offspring inflammation at 25 years: a prospective longitudinal cohort study. Transl Psychiatry. 2016;6(11):e936. PubMed CrossRef
  9. Weissman MM, Wickramaratne P, Nomura Y, et al. Offspring of depressed parents: 20 years later. Am J Psychiatry. 2006;163(6):1001–1008. PubMed CrossRef
  10. Oppo A, Mauri M, Ramacciotti D, et al. Risk factors for postpartum depression: the role of the Postpartum Depression Predictors Inventory-Revised (PDPI-R): results from the Perinatal Depression-Research & Screening Unit (PNDReScU) study. Arch Women Ment Health. 2009;12(4):239–249. PubMed CrossRef
  11. Beck CT. Predictors of postpartum depression: an update. Nurs Res. 2001;50(5):275–285. PubMed CrossRef
  12. Reck C, Stehle E, Reinig K, et al. Maternity blues as a predictor of DSM-IV depression and anxiety disorders in the first three months postpartum. J Affect Disord. 2009;113(1–2):77–87. PubMed CrossRef
  13. Wilson N, Wynter K, Anderson C, et al. More than depression: a multi-dimensional assessment of postpartum distress symptoms before and after a residential early parenting program. BMC Psychiatry. 2019;19(1):48. PubMed CrossRef
  14. Tomfohr LM, Buliga E, Letourneau NL, et al. Trajectories of sleep quality and associations with mood during the perinatal period. Sleep (Basel). 2015;38(8):1237–1245. PubMed CrossRef
  15. Osnes RS, Eberhard-Gran M, Follestad T, et al. Mid-pregnancy insomnia is associated with concurrent and postpartum maternal anxiety and obsessive-compulsive symptoms: a prospective cohort study. J Affect Disord. 2020;266:319–326. PubMed CrossRef
  16. Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci. 2008;10(4):473–481. PubMed CrossRef
  17. Zanardo V, Manghina V, Giliberti L, et al. Psychological impact of COVID-19 quarantine measures in northeastern Italy on mothers in the immediate postpartum period. Int J Gynaecol Obstet. 2020;150(2):184–188. PubMed CrossRef
  18. Wu Y, Zhang C, Liu H, et al. Perinatal depressive and anxiety symptoms of pregnant women during the coronavirus disease 2019 outbreak in China. Am J Obstet Gynecol. 2020;223(2):240.e1–240.e9. PubMed CrossRef
  19. Boekhorst MG, Muskens L, Hulsbosch LP, et al. The COVID-19 outbreak increases maternal stress during pregnancy, but not the incidence of postpartum depression. 2021.
  20. Cameron EE, Joyce KM, Delaquis CP, et al. Maternal psychological distress & mental health service use during the COVID-19 pandemic. J Affect Disord. 2020;276:765–774. PubMed CrossRef
  21. Lebel C, MacKinnon A, Bagshawe M, et al. Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic. J Affect Disord. 2020;277:5–13. PubMed CrossRef
  22. Preis H, Mahaffey B, Lobel M. Psychometric properties of the Pandemic-Related Pregnancy Stress Scale (PREPS). J Psychosom Obstet Gynaecol. 2020;41(3):191–197. PubMed CrossRef
  23. Ceulemans M, Hompes T, Foulon V. Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic: a call for action. Int J Gynaecol Obstet. 2020;151(1):146–147. PubMed CrossRef
  24. Saccone G, Florio A, Aiello F, et al. Psychological impact of coronavirus disease 2019 in pregnant women. Am J Obstet Gynecol. 2020;223(2):293–295. PubMed CrossRef
  25. Davenport MH, Meyer S, Meah VL, et al. Moms are not OK: COVID-19 and maternal mental health. Frontiers in Global Women’s Health. 2020;1:1. CrossRef
  26. Allotey J, Stallings E, Bonet M, et al; for PregCOV-19 Living Systematic Review Consortium. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. PubMed CrossRef
  27. Zambrano LD, Ellington S, Strid P, et al; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641–1647. PubMed CrossRef
  28. Farewell CV, Jewell J, Walls J, et al. A mixed-methods pilot study of perinatal risk and resilience during COVID-19. J Prim Care Community Health. 2020;11:2150132720944074. PubMed CrossRef
  29. Lee EH, Kepler KL, Geevarughese A, et al. Race/ethnicity among children with COVID-19-associated multisystem inflammatory syndrome. JAMA Netw Open. 2020;3(11):e2030280. PubMed CrossRef
  30. Price-Haywood EG, Burton J, Fort D, et al. Hospitalization and mortality among black patients and white patients with COVID-19. N Engl J Med. 2020;382(26):2534–2543. PubMed CrossRef
  31. Miu AC, Heilman RM, Houser D. Anxiety impairs decision-making: psychophysiological evidence from an Iowa Gambling Task. Biol Psychol. 2008;77(3):353–358. PubMed CrossRef
  32. Bishop SJ, Gagne C. Anxiety, depression, and decision making: a computational perspective. Annu Rev Neurosci. 2018;41(1):371–388. PubMed CrossRef
  33. Gao F, Zheng KI, Wang X-B, et al. Obesity is a risk factor for greater COVID-19 severity. Diabetes Care. 2020;43(7):e72–e74. PubMed CrossRef
  34. Grasselli G, Greco M, Zanella A, et al; COVID-19 Lombardy ICU Network. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345–1355. PubMed CrossRef
  35. Kalligeros M, Shehadeh F, Mylona EK, et al. Association of obesity with disease severity among patients with coronavirus disease 2019. Obesity (Silver Spring). 2020;28(7):1200–1204. PubMed CrossRef
  36. Milgrom J, Gemmill AW, Ericksen J, et al. Treatment of postnatal depression with cognitive behavioural therapy, sertraline and combination therapy: a randomised controlled trial. Aust N Z J Psychiatry. 2015;49(3):236–245. PubMed CrossRef
  37. Meager I, Milgrom J. Group treatment for postpartum depression: a pilot study. Aust N Z J Psychiatry. 1996;30(6):852–860. PubMed CrossRef
  38. Huang L, Zhao Y, Qiang C, et al. Is cognitive behavioral therapy a better choice for women with postnatal depression? a systematic review and meta-analysis. PLoS One. 2018;13(10):e0205243. PubMed CrossRef  
  39. O’Hara MW, Stuart S, Gorman LL, et al. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry. 2000;57(11):1039–1045. PubMed CrossRef
  40. Spinelli MG, Endicott J. Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women. Am J Psychiatry. 2003;160(3):555–562. PubMed CrossRef
  41. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295(5):499–507. PubMed CrossRef
  42. ACOG Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 92, April 2008 (replaces practice bulletin number 87, November 2007): use of psychiatric medications during pregnancy and lactation. Obstet Gynecol. 2008;111(4):1001–1020. PubMed CrossRef
  43. Vargas-Terrones M, Barakat R, Santacruz B, et al. Physical exercise programme during pregnancy decreases perinatal depression risk: a randomised controlled trial. Br J Sports Med. 2019;53(6):348–353. PubMed CrossRef
  44. Bayrampour H, Kapoor A, Bunka M, et al. The risk of relapse of depression during pregnancy after discontinuation of antidepressants: a systematic review and meta-analysis. J Clin Psychiatry. 2020;81(4):19r13134. PubMed CrossRef
  45. Donker T, Griffiths KM, Cuijpers P, et al. Psychoeducation for depression, anxiety, and psychological distress: a meta-analysis. BMC Med. 2009;7(1):79. PubMed CrossRef
  46. Elliott SA, Leverton TJ, Sanjack M, et al. Promoting mental health after childbirth: a controlled trial of primary prevention of postnatal depression. Br J Clin Psychol. 2000;39(3):223–241. PubMed CrossRef
  47. Fisher JRW, Wynter KH, Rowe HJ. Innovative psycho-educational program to prevent common postpartum mental disorders in primiparous women: a before and after controlled study. BMC Public Health. 2010;10(1):432. PubMed CrossRef
  48. Pierce BS, Perrin PB, Tyler CM, et al. The COVID-19 telepsychology revolution: a national study of pandemic-based changes in US mental health care delivery. Am Psychol. 2021;76(1):14–25. PubMed CrossRef
  49. American College of Obstetricians and Gynecologists. ACOG Committee opinion No. 757: screening for perinatal depression. Obstet Gynecol. 2018;132(5):e208–e212. PubMed CrossRef
  50. Sivertsen B, Hysing M, Dørheim SK, et al. Trajectories of maternal sleep problems before and after childbirth: a longitudinal population-based study. BMC Pregnancy Childbirth. 2015;15(1):129. PubMed CrossRef
  51. Hedman C, Pohjasvaara T, Tolonen U, et al. Effects of pregnancy on mothers’ sleep. Sleep Med. 2002;3(1):37–42. PubMed CrossRef
  52. Leung PL, Hui DSC, Leung TN, et al. Sleep disturbances in Chinese pregnant women. BJOG. 2005;112(11):1568–1571. PubMed CrossRef
  53. Driver HS, Shapiro CM. A longitudinal study of sleep stages in young women during pregnancy and postpartum. Sleep. 1992;15(5):449–453. PubMed CrossRef
  54. Thomas KA, Foreman SW. Infant sleep and feeding pattern: effects on maternal sleep. J Midwifery Womens Health. 2005;50(5):399–404. PubMed CrossRef
  55. Sharma SK, Nehra A, Sinha S, et al. Sleep disorders in pregnancy and their association with pregnancy outcomes: a prospective observational study. Sleep Breath. 2016;20(1):87–93. PubMed CrossRef
  56. Hashmi AM, Bhatia SK, Bhatia SK, et al. Insomnia during pregnancy: diagnosis and rational interventions. Pak J Med Sci. 2016;32(4):1030–1037. PubMed
  57. Smith MT, Huang MI, Manber R. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev. 2005;25(5):559–592. PubMed CrossRef
  58. Manber R, Bei B, Simpson N, et al. Cognitive behavioral therapy for prenatal insomnia: a randomized controlled trial. Obstet Gynecol. 2019;133(5):911–919. PubMed CrossRef
  59. Morin CM, Vallières A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005–2015. PubMed CrossRef
  60. Swanson LM, Flynn H, Adams-Mundy JD, et al. An open pilot of cognitive-behavioral therapy for insomnia in women with postpartum depression. Behav Sleep Med. 2013;11(4):297–307. PubMed CrossRef
  61. Mullington JM, Simpson NS, Meier-Ewert HK, et al. Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab. 2010;24(5):775–784. PubMed CrossRef
  62. Maes M, Berk M, Goehler L, et al. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 2012;10(1):66. PubMed CrossRef
  63. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–741. PubMed CrossRef
  64. Tasali E, Leproult R, Ehrmann DA, et al. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A. 2008;105(3):1044–1049. PubMed CrossRef
  65. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest. 2010;137(1):95–101. PubMed CrossRef
  66. Gray KJ, Bordt EA, Atyeo C, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021;225(3):303.e1–303.e17. PubMed CrossRef
  67. Kominiarek MA, Rajan P. Nutrition recommendations in pregnancy and lactation. Med Clin North Am. 2016;100(6):1199–1215. PubMed CrossRef
  68. World Health Organization. Essential Nutrition Actions: Mainstreaming Nutrition Through the Life-Course. Geneva, Swtizerland: World Health Organization; 2019.
  69. Beard JL, Hendricks MK, Perez EM, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr. 2005;135(2):267–272. PubMed CrossRef
  70. Leung BMY, Kaplan BJ. Perinatal depression: prevalence, risks, and the nutrition link—a review of the literature. J Am Diet Assoc. 2009;109(9):1566–1575. PubMed CrossRef
  71. Robinson M, Whitehouse AJ, Newnham JP, et al. Low maternal serum vitamin D during pregnancy and the risk for postpartum depression symptoms. Arch Women Ment Health. 2014;17(3):213–219. PubMed CrossRef
  72. Accortt EE, Schetter CD, Peters RM, et al. Lower prenatal vitamin D status and postpartum depressive symptomatology in African American women: preliminary evidence for moderation by inflammatory cytokines. Arch Women Ment Health. 2016;19(2):373–383. PubMed CrossRef
  73. Bibbins-Domingo K, Grossman DC, Curry SJ, et al; US Preventive Services Task Force. Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(2):183–189. PubMed CrossRef
  74. Levine SZ, Kodesh A, Viktorin A, et al. Association of maternal use of folic acid and multivitamin supplements in the periods before and during pregnancy with the risk of autism spectrum disorder in offspring. JAMA Psychiatry. 2018;75(2):176–184. PubMed CrossRef
  75. Eryilmaz H, Dowling KF, Huntington FC, et al. Association of prenatal exposure to population-wide folic acid fortification with altered cerebral cortex maturation in youths. JAMA Psychiatry. 2018;75(9):918–928. PubMed CrossRef
  76. Canfield MA, Collins JS, Botto LD, et al; National Birth Defects Prevention Network. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol. 2005;73(10):679–689. PubMed CrossRef
  77. Schuch FB, Vancampfort D, Richards J, et al. Exercise as a treatment for depression: a meta-analysis adjusting for publication bias. J Psychiatr Res. 2016;77:42–51. PubMed CrossRef
  78. Aylett E, Small N, Bower P. Exercise in the treatment of clinical anxiety in general practice—a systematic review and meta-analysis. BMC Health Serv Res. 2018;18(1):559. PubMed CrossRef
  79. Babyak M, Blumenthal JA, Herman S, et al. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000;62(5):633–638. PubMed CrossRef
  80. Gong H, Ni C, Shen X, et al. Yoga for prenatal depression: a systematic review and meta-analysis. BMC Psychiatry. 2015;15(1):14. PubMed CrossRef
  81. Newham JJ, Wittkowski A, Hurley J, et al. Effects of antenatal yoga on maternal anxiety and depression: a randomized controlled trial. Depress Anxiety. 2014;31(8):631–640. PubMed CrossRef
  82. Harvey SB, Øverland S, Hatch SL, et al. Exercise and the prevention of depression: results of the HUNT Cohort Study. Am J Psychiatry. 2018;175(1):28–36. PubMed CrossRef
  83. El-Rafie MM, Khafagy GM, Gamal MG. Effect of aerobic exercise during pregnancy on antenatal depression. Int J Womens Health. 2016;8:53–57. PubMed
  84. Pritchett RV, Daley AJ, Jolly K. Does aerobic exercise reduce postpartum depressive symptoms? a systematic review and meta-analysis. Br J Gen Pract. 2017;67(663):e684–e691. PubMed CrossRef
  85. Yang PY, Ho KH, Chen HC, et al. Exercise training improves sleep quality in middle-aged and older adults with sleep problems: a systematic review. J Physiother. 2012;58(3):157–163. PubMed CrossRef
  86. Coll CVN, Domingues MR, Stein A, et al. Efficacy of regular exercise during pregnancy on the prevention of postpartum depression: the PAMELA randomized clinical trial. JAMA Netw Open. 2019;2(1):e186861. PubMed CrossRef
  87. Milgrom J, Negri LM, Gemmill AW, et al. A randomized controlled trial of psychological interventions for postnatal depression. Br J Clin Psychol. 2005;44(Pt 4):529–542. PubMed CrossRef
  88. Almeida M, Shrestha AD, Stojanac D, et al. The impact of the COVID-19 pandemic on women’s mental health. Arch Women Ment Health. 2020;23(6):741–748. PubMed CrossRef
  89. Milgrom J, Holt C, Holt CJ, et al. Feasibility study and pilot randomised trial of an antenatal depression treatment with infant follow-up. Arch Women Ment Health. 2015;18(5):717–730. PubMed CrossRef
  90. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150(6):782–786. PubMed CrossRef
  91. Felder JN, Laraia B, Coleman-Phox K, et al. Poor sleep quality, psychological distress, and the buffering effect of mindfulness training during pregnancy. Behav Sleep Med. 2018;16(6):611–624. PubMed CrossRef
  92. Khazaie H, Ghadami MR, Knight DC, et al. Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomized clinical trial. Psychiatry Res. 2013;210(3):901–905. PubMed CrossRef
Download Free PDF

Enjoy free PDF downloads as part of your membership!

Save Save

Share Share

Cite Cite

Vol 26 • 2024 • Number 4

Read the Current Issue

Narrative Review

Management of ADHD in Adolescents and Young Adults

Narrative Review

Tech Gaming Designs, Neurodevelopmental Vulnerabilities, and Internet Gaming Disorder Risk

Original Research

Presentation and Outcome of MCI

Original Research

Dementia Mortality Patterns in the United States

Rounds in the General Hospital

Pharmacologic Management of TBI

Rounds in the General Hospital

Evaluation and Management of Treatment-Resistant Schizophrenia
View current Issue

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe